About alfa glucosidaze myozyme
Enzyme replacement therapy
Used for
- Long-term treatment of Pompe disease (acid alpha-glucosidase deficiency)
Usual adult dose
20 mg/kg intravenously every two weeks.
Usual dose in children
20 mg/kg intravenously every two weeks.
Common side effects
- Allergic or infusion-related reactions
- Fever
- Rash or hives
- Vomiting
Important warnings
- Severe allergic reactions, including anaphylaxis, can occur.
- Infusion reactions may require slowing or stopping treatment.
- Breathing or heart problems may increase infusion-reaction risk.
- Antibodies may reduce treatment response or contribute to reactions.
Pregnancy
Use only when clearly needed; evidence in pregnancy is limited.
Breastfeeding
Human data are limited; discuss benefits and uncertainties with a healthcare professional.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.